期刊文献+

CCR2和CCR5基因多态性与结核性脓胸的关系

Association of CCR2 gene and CCR5 gene polymorphisms with the risk of tuberculous empyema
下载PDF
导出
摘要 目的探讨CCR2基因-190 G/A和CCR5基因-59029 G/A单核苷酸多态性(SNP)与结核性脓胸的关系。方法采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对结核性脓胸患者300例和健康对照组300例进行CCR2基因-190 G/A和CCR5基因-59029 G/A SNPs检测。结果与CCR2基因-190 GG基因型相比,携带AG和AA基因型均可增加结核性脓胸发病风险(OR=2.254,95%CI 1.043~4.868;OR=8.728,95%CI 4.224~18.033)。进行分层分析发现,无卡介苗(BCG)接种史、体质量指数(BMI)<18.5 kg/m^2均增加结核性脓胸发病风险(OR=3.309,95%CI 2.108~4.382;OR=2.767,95%CI 1.918~3.993)。CCR5基因-59029 G/A各基因型未入选回归方程,无统计学意义(P>0.05)。结论CCR2基因-190 G/A SNP可能与结核性脓胸的发病风险有关;CCR5基因-59029 G/A SNP可能与结核性脓胸无关。 Objective To investigate the relationship of CCR2 gene-190 G/A, CCR5 gene-59029 G/A single nucle-otide polymorphism ( SNP) and tuberculous empyema. Methods Using polymerase chain reaction restriction fragment length polymorphism ( PCR-RFLP) method, 300 cases of tuberculous empyema patients and 300 healthy control were received 190 G/A and 59029 G/A SNPs detection. Results Compared to CCR2 gene-190 GG genotype, carrying AG and AA genotype can increase the risk of tuberculous empyema ( OR =2. 254, 95%CI 1. 043 -4. 868; OR =8. 728, 95%CI 4. 224 -18. 033). Stratified analysis revealed that, without Bacillus Calmette Guerin (BCG) vaccination history, body mass index (BMI) 〈18. 5 kg/m^2 were all increased the risk of tuberculous empyema (OR=3. 309, 95%CI 2. 108 -4. 382; OR=2. 767, 95%CI 1. 918-3. 993). CCR5 gene-59029 G/A genotypes were not selected in the regression equation, no statisti-cal significance was found ( P 〉0. 05). Conclusion CCR2 gene-190 G/A SNP might be related to the tuberculous empye-ma. CCR5 gene-59029 G/A SNP may have no association with tuberculous empyema.
出处 《疑难病杂志》 CAS 2015年第2期141-144,共4页 Chinese Journal of Difficult and Complicated Cases
关键词 结核性脓胸 CCR2基因 CCR5基因 单核苷酸多态性 Tuberculous empyema CCR2 gene CCR5 gene Single nucleotide polymorphism
  • 相关文献

参考文献9

  • 1Sezgin I, Koksal B, Bagci G, et al. CCR2 poIymorphism in chronic renal failure patients requiring long-term hemodialysis[ J]. Internal Medicine, 2011,50(21 ) :2457-2461.
  • 2王睿,张松,时立新.CCR5基因启动子多态性与2型糖尿病肾病相关性研究[J].贵州医药,2007,31(6):500-503. 被引量:2
  • 3Miyagishi R, Niino M, Fukazawa T, et al. C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis [ J ], Neuroimmuno1,2003,145 ( 1/2 ) : 135-138.
  • 4韩锐,綦辉,孙琳,申阿东.CCR2、CCL5、CCR5和CCL1基因多态性与中国汉族儿童结核病易感性的关联研究[J].标记免疫分析与临床,2014,21(2):171-175. 被引量:6
  • 5Mishra G, Poojary SS, Raj P, et al. Genetic polymorthisms of CCL2 CCL5,CCR2 and CCR5 genes in Saharlya tribe of North Central India an association study with pulmonary tuberculosis [ J ]. Infect Genet Evol 2012,12(5) :1120-1127.
  • 6盛磊,常生军,程江.CCR5基因多态性的研究进展[J].实用医技杂志,2007,14(4):429-430. 被引量:3
  • 7Nakajima K, Tanaka Y, Nomiyama T, et al. Chemokine receptor geno- type is associated with diabetic nephropathy in Japanese with type 2 dia- betes [ J ]. Diabetes,2002,51 ( 1 ) :238-242.
  • 8Smith MW, Dean M, Carting T, et al. Comtrasting genetic influence of CCR2 and CCR5 variant son HIV-I infection and disease progression [ J ]. Science, 1997,277 ( 5328 ) : 959 -965.
  • 9Mamtani M, Mummidi S, Ramsuran V, et al. Influence of variations in CCL3 L1 and CCR5 on tuberculosis in a northwestern Colombian popula- tion [ J ]. J Infect Dis,2011,203 ( 11 ) : 1590-1594.

二级参考文献40

  • 1江载芳,赵顺英.儿童肺结核的临床诊断标准和治疗方案(试行)[J].中华儿科杂志,2006,44(4):249-251. 被引量:134
  • 2[1]Krolewski A S.Genetics of diabetic nephropathy:evidence for major and minor gene effects.Kidney Int,1999,55(4):1 582-96.
  • 3[2]Sc Hondorff D,Nelson PJ,Luckow B,et al.Chemokines and renal disease[J].Kidney Int,1997,51(3):610-21.
  • 4[3]Sassy-Prigent C,Heudes D,Mandetc,et al.Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats[J].Diabetes,2000,49:466-475.
  • 5[4]Furuta T,Saito T,Ootaka T,et al.The role of macrophages in diabetic glomerulosclerosis[J].Am J Kidney Dis,1993,21(5):480-581.
  • 6[5]Luster AD.Chemokines-chemotactic cytokines that mediate inflammation[J].N Engl J Med 1998,338:436-445.
  • 7[6]Nomiyama T,Ogihara Y,et al.Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes.Diabetes,2002,51:238-242.
  • 8[7]Nomiyama T,Ogihara T,Tanaka Tet al.RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects[J].Diabetes Care,2003,26:892-898.
  • 9[8]Takashi W,Hitoshi Y,Kouji M,et al.Monocyte chemoattractant protein-l:does it play a role in diabetic nephropathy[J]? Nephrol Dial Transplant,2003,18:457-459.
  • 10[9]Lapage J,Wang SN.Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.Kidney Int,2000,58:1 492-1 499.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部